13F HOLDINGS REPORT
TAKEDA PHARMACEUTICAL CO LTD
Quarter ended Q4 2024 · Filed February 12, 2025 · Accession 0001395064-25-000019
Total Value
$26.6M
Positions
12
Other Managers
1
Confidential Omitted
No
Holdings (12)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | HilleVax, Inc. | 43157M102 | 6,724,000 | $13.9M | 52.40% |
| 2 | Ovid Therapeutics Inc. | OVID | 5,750,000 | $5.3M | 20.13% |
| 3 | Ovid Therapeutics Inc. | OVID | 1,781,996 | $1.7M | 6.27% |
| 4 | Xilio Therapeutics, Inc. | XLO | 1,475,121 | $1.4M | 5.33% |
| 5 | Equillium, Inc. | EQ | 1,824,977 | $1.4M | 5.15% |
| 6 | Shattuck Labs, Inc. | STTK | 515,619 | $623,899 | 2.35% |
| 7 | American Well Corp | AMWL | 77,733 | $563,564 | 2.12% |
| 8 | Lyell Immunopharma, Inc. | LYEL | 823,317 | $526,923 | 1.98% |
| 9 | Turnstone Biologics Corp. | 90042W100 | 895,824 | $447,912 | 1.69% |
| 10 | Third Harmonic Bio, Inc. | 88427A107 | 36,835 | $379,032 | 1.43% |
| 11 | Rani Therapeutics Holdings, Inc. | RANI | 203,190 | $278,370 | 1.05% |
| 12 | STANDARD BIOTOOLS INC. | LAB | 16,515 | $28,901 | 0.11% |